Inhaled corticosteroids in COPD: awaiting controlled trials.
Open Access
- 1 April 1993
- Vol. 48 (4) , 305-307
- https://doi.org/10.1136/thx.48.4.305
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.Thorax, 1993
- Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.BMJ, 1991
- Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.Thorax, 1991
- Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.Thorax, 1990
- The use of high dose inhaled beclomethasone dipropionate as a means of assessing steroid responsiveness in obstructive airways diseaseRespiratory Medicine, 1988
- Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study.Thorax, 1988
- Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy.Thorax, 1987
- EFFECTS OF PREDNISOLONE IN CHRONIC AIRFLOW LIMITATIONThe Lancet, 1984
- Corticosteroids in chronic bronchitis.BMJ, 1984
- A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response.Thorax, 1978